Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $399.5100 (3.92%) ($384.2700 - $399.5700) on Mon. Sep. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 38 | Latest Price | $399.5100(3.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -0.97% in a week (0% probabilities). VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | 0 () | Intraday Trend | 4% | | | |
|
Resistance Level | $402.7 | 5 Day Moving Average | $396.79(0.69%) | 10 Day Moving Average | $395.32(1.06%) | 20 Day Moving Average | $402.7(-0.79%) | To recent high | -9.5% | To recent low | 20.7% | Market Cap | $42.36b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |